AU2013221604B2 - Methods for treating an impairment in gait and/or balance in patients with multiple sclerosis using an aminopyridine - Google Patents

Methods for treating an impairment in gait and/or balance in patients with multiple sclerosis using an aminopyridine Download PDF

Info

Publication number
AU2013221604B2
AU2013221604B2 AU2013221604A AU2013221604A AU2013221604B2 AU 2013221604 B2 AU2013221604 B2 AU 2013221604B2 AU 2013221604 A AU2013221604 A AU 2013221604A AU 2013221604 A AU2013221604 A AU 2013221604A AU 2013221604 B2 AU2013221604 B2 AU 2013221604B2
Authority
AU
Australia
Prior art keywords
balance
aminopyridine
gait
patient
drug
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2013221604A
Other languages
English (en)
Other versions
AU2013221604A1 (en
Inventor
Cecilie FJELDSTAD
Gabriel PARDO
Gustavo Adolfo Suarez Zambrano
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Acorda Therapeutics Inc
Original Assignee
Acorda Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Acorda Therapeutics Inc filed Critical Acorda Therapeutics Inc
Publication of AU2013221604A1 publication Critical patent/AU2013221604A1/en
Application granted granted Critical
Publication of AU2013221604B2 publication Critical patent/AU2013221604B2/en
Ceased legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4409—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 4, e.g. isoniazid, iproniazid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Psychology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2013221604A 2012-02-13 2013-02-13 Methods for treating an impairment in gait and/or balance in patients with multiple sclerosis using an aminopyridine Ceased AU2013221604B2 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201261598332P 2012-02-13 2012-02-13
US61/598,332 2012-02-13
US201261677466P 2012-07-30 2012-07-30
US61/677,466 2012-07-30
PCT/US2013/025979 WO2013123083A1 (en) 2012-02-13 2013-02-13 Methods for treating an impairment in gait and/or balance in patients with multiple sclerosis using an aminopyridine

Publications (2)

Publication Number Publication Date
AU2013221604A1 AU2013221604A1 (en) 2014-08-28
AU2013221604B2 true AU2013221604B2 (en) 2017-11-23

Family

ID=47755034

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2013221604A Ceased AU2013221604B2 (en) 2012-02-13 2013-02-13 Methods for treating an impairment in gait and/or balance in patients with multiple sclerosis using an aminopyridine

Country Status (12)

Country Link
US (9) US20130210866A1 (https=)
EP (2) EP2814492A1 (https=)
JP (1) JP6155284B2 (https=)
AU (1) AU2013221604B2 (https=)
BR (1) BR112014020102A8 (https=)
CA (1) CA2864340A1 (https=)
CO (1) CO7151515A2 (https=)
EA (1) EA201491522A1 (https=)
IL (1) IL234057B (https=)
MX (1) MX2014009811A (https=)
WO (1) WO2013123083A1 (https=)
ZA (1) ZA201405887B (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10289679B2 (en) * 2014-12-10 2019-05-14 International Business Machines Corporation Data relationships in a question-answering environment
US10972297B2 (en) 2017-01-23 2021-04-06 Bank Of America Corporation Data processing system with machine learning engine to provide automated collaboration assistance functions
US10297255B2 (en) 2017-01-23 2019-05-21 Bank Of America Corporation Data processing system with machine learning engine to provide automated collaboration assistance functions

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050228030A1 (en) * 2004-04-09 2005-10-13 Blight Andrew R Method of using sustained release aminopyridine compositions
WO2010093838A1 (en) * 2009-02-11 2010-08-19 Acorda Therapeutics, Inc. Compostions and methods for using aminopyridines

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE82916B1 (en) 1990-11-02 2003-06-11 Elan Corp Plc Formulations and their use in the treatment of neurological diseases
US5952357A (en) 1993-12-23 1999-09-14 Cornell Research Foundation, Inc. Treating diseases of the anterior horn cells
US8007826B2 (en) 2003-12-11 2011-08-30 Acorda Therapeutics, Inc. Sustained release aminopyridine composition
TW201010703A (en) * 2008-09-10 2010-03-16 Acorda Therapeutics Inc Methods of using sustained release aminopyridine compositions

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050228030A1 (en) * 2004-04-09 2005-10-13 Blight Andrew R Method of using sustained release aminopyridine compositions
WO2010093838A1 (en) * 2009-02-11 2010-08-19 Acorda Therapeutics, Inc. Compostions and methods for using aminopyridines

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
HAYES K C, NEUROPSYCHIATRIC DISEASE AND TREATMENT 2011 DOVE MEDICAL PRESS LTD. NZL, (2011), vol. 7, no. 1, ISSN 1176-6328, pages 229 - 239 *
WINCHESTER P K ET AL, MEDICINE AND SCIENCE IN SPORTS AND EXERCISE, & 47TH ANNUAL MEETING OF THE AMERICAN COLLEGE OF SPORTS MEDICINE.; MAY 31-JUNE 03, 2000, (200005), vol. 32, no. 5 Suppl., ISSN 0195-9131, page S264 *

Also Published As

Publication number Publication date
EP2814492A1 (en) 2014-12-24
US20130210866A1 (en) 2013-08-15
ZA201405887B (en) 2022-01-26
US20200230121A1 (en) 2020-07-23
EA201491522A1 (ru) 2014-12-30
IL234057B (en) 2018-11-29
CA2864340A1 (en) 2013-08-22
IL234057A0 (en) 2014-09-30
US20170165244A1 (en) 2017-06-15
US20160067230A1 (en) 2016-03-10
AU2013221604A1 (en) 2014-08-28
EP3381455A1 (en) 2018-10-03
US20180028513A1 (en) 2018-02-01
US20190134016A1 (en) 2019-05-09
US20190381021A1 (en) 2019-12-19
JP2015509934A (ja) 2015-04-02
US20180256556A1 (en) 2018-09-13
JP6155284B2 (ja) 2017-06-28
BR112014020102A8 (pt) 2017-07-11
CO7151515A2 (es) 2014-12-29
BR112014020102A2 (https=) 2017-06-20
WO2013123083A1 (en) 2013-08-22
US20160303097A1 (en) 2016-10-20
MX2014009811A (es) 2014-09-08

Similar Documents

Publication Publication Date Title
JP2012517449A (ja) アミノピリジンによる長期治療のための組成物及び方法
US20130030025A1 (en) Use of potassium channel blockers to treat cerebral palsy
JP6313414B2 (ja) 外傷性傷害の処置におけるレボセチリジン及びモンテルカストの使用
US20200230121A1 (en) Methods for treating an impairment in gait and/or balance in patients with multiple sclerosis using an aminopyridine
Egeberg et al. Clinical overview of dalfampridine: an agent with a novel mechanism of action to help with gait disturbances
KR20120050512A (ko) 탈수초를 갖는 환자에서 ４-아미노피리딘을 사용한 지속적 치료
AU2018200114A1 (en) Methods for treating a stroke-related sensorimotor impairment using aminopyridines
WO2014093475A1 (en) Methods for treating parkinson's disease using aminopyridines
JP7852200B2 (ja) ウィルソン病を治療するためのビスコリンテトラチオモリブデート
WO2014028387A1 (en) Methods for improving walking capacity in patients with multiple sclerosis using an aminopyridine
JP2018127497A (ja) アミノピリジンを使用した、ある種の卒中に関連した感覚運動障害を治療するための方法
HK1157591A (en) Compositions and methods for extended therapy with aminopyridines
EA041256B1 (ru) Применение придопидина для лечения ухудшения функциональной способности
NZ623255B2 (en) Methods for treating a stroke-related sensorimotor impairment using aminopyridines

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired